But I do wonder how easy it will be to get a research-level DNA sequence if sequencing manages to get on the medical reimbursement gravy train.

FORBES: Debating The $1,000 Genome

George Church, a molecular geneticist at Harvard Medical School and a pioneer of whole-genome sequencing, is unpersuaded.

ECONOMIST: Patenting genes is bad for diagnosis

In the same breath, the article mentions DNA sequencing company Pacific Biosciences, as well as Glaukos and NeuroPace which sell medical devices.

FORBES: Why The Numbers On Health IT Venture Funding Are Confusing

The chief executive of a major maker of DNA sequencing technology is talking about getting regulatory clearance to use his technology for medical purposes.

FORBES: Can A DNA Sequencer Get FDA Approval?